메뉴 건너뛰기




Volumn 23, Issue SUPPL., 2004, Pages

Ensuring that consumers receive appropriate information from drug ads: What is the FDA's role?

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; CONSUMER; DRUG INFORMATION; DRUG LEGISLATION; DRUG MARKETING; DRUG SAFETY; EDUCATION; FOOD AND DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRESCRIPTION; SHORT SURVEY;

EID: 4644267927     PISSN: 02782715     EISSN: None     Source Type: Journal    
DOI: 10.1377/hlthaff.W4.256     Document Type: Short Survey
Times cited : (7)

References (6)
  • 1
    • 4644250772 scopus 로고    scopus 로고
    • Physicians Report on Patient Encounters Involving Direct-to-Consumer Advertising
    • 28 April, 28 April 2004
    • J.S. Weissman et al., "Physicians Report on Patient Encounters Involving Direct-to-Consumer Advertising," Health Affairs, 28 April 2004, content.healthaffairs.org/cgi/content/abstract/hlthaff.w4.219 (28 April 2004); and S. Woloshin et al., "The Value of Benefit Data in Direct-to-Consumer Drug Ads," Health Affairs, 28 April 2004, content.healthaffairs.org/cgi/ content/abstract/hlthaff.w4.234 (28 April 2004).
    • (2004) Health Affairs
    • Weissman, J.S.1
  • 2
    • 4644257281 scopus 로고    scopus 로고
    • The Value of Benefit Data in Direct-to-Consumer Drug Ads
    • 28 April, 28 April 2004
    • J.S. Weissman et al., "Physicians Report on Patient Encounters Involving Direct-to-Consumer Advertising," Health Affairs, 28 April 2004, content.healthaffairs.org/cgi/content/abstract/hlthaff.w4.219 (28 April 2004); and S. Woloshin et al., "The Value of Benefit Data in Direct-to-Consumer Drug Ads," Health Affairs, 28 April 2004, content.healthaffairs.org/cgi/ content/abstract/hlthaff.w4.234 (28 April 2004).
    • (2004) Health Affairs
    • Woloshin, S.1
  • 3
    • 4644341143 scopus 로고    scopus 로고
    • Letter from Rep. Henry A. Waxman to the Honorable Tommy G. Thompson, 1 October, 6 April 2004
    • Letter from Rep. Henry A. Waxman to the Honorable Tommy G. Thompson, 1 October 2002, www.house.gov/reform/min/inves_prescrip/prescrip_drug_ads.htm (6 April 2004).
    • (2002)
  • 5
    • 4644296761 scopus 로고    scopus 로고
    • Letter from FDA Commissioner Mark B. McClellan to Rep. Henry A. Waxman, 31 March 2003
    • Letter from FDA Commissioner Mark B. McClellan to Rep. Henry A. Waxman, 31 March 2003.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.